Valerian root research shows modest, inconsistent evidence for improving self-reported sleep quality and easing situational anxiety, but objective measures like polysomnography find little real change, making cognitive behavioral therapy a stronger, more reliably evidence-based option for persistent insomnia or ongoing anxiety.
What if that valerian root capsule you swallow before bed is working on your mind but not your actual sleep? Research shows people often feel calmer and rested, yet brain recordings tell a different story. Here's what's really happening, and what helps when the real problem is anxiety.
What valerian root is and what is actually in the bottle
Valerian refers to preparations made from the root and rhizome of Valeriana officinalis, a flowering plant used for a long time in Europe and North America as a remedy for sleep disorders and general nervous tension. People also reach for it around anxiety, since calm and sleep tend to overlap in how the plant is marketed. What you find on a store shelf varies widely. Valerian tablets for sleep are the most common form, but you will also see capsules, liquid tinctures, loose or bagged teas, and combination products that blend valerian with hops, lemon balm, or passionflower.
There is no single active ingredient in valerian. The root contains a mix of compounds, including valerenic acid and a group called valepotriates, and the amount of each varies from plant to plant and batch to batch. Some extracts are standardized to contain a set percentage of valerenic acid, which is meant to make dosing more consistent. Many products carry no standardization at all, so the label tells you almost nothing about what is actually inside.
This matters because valerian is sold as a dietary supplement, not a drug. Supplement manufacturers are not required to verify content or potency before a product reaches the shelf the way a prescription medication would be. Two bottles with identical labels can contain meaningfully different amounts of the plant’s active constituents. That inconsistency is worth keeping in mind if you ever try to compare your own experience with valerian against what a study reported, since the study may have used a preparation nothing like the one in your hand.
The evidence scorecard: what the major reviews actually found
Asking what valerian root actually does for sleep and anxiety according to research means looking past any single trial and toward what the pooled reviews show once you line them up side by side. Each review used different studies, different quality thresholds, and different ways of measuring rest and calm. The pattern that emerges is consistent enough to matter, and inconsistent enough to explain why the supplement aisle and the research literature seem to disagree.
How to read the scorecard
Here is a plain-language summary of the major reviews on valerian, with what each one actually measured and found.
- Umbrella review (2024): reviewed multiple prior systematic reviews on valerian for insomnia. Outcome type: mostly subjective (self-reported sleep quality). Result: no evidence of efficacy on objective measures, though subjective sleep ratings improved. Quality note: the umbrella review describes the underlying evidence as low methodological quality, inconsistent, and thin.
- 2020 systematic review and meta-analysis: pooled 60 studies covering 6,894 participants. Outcome type: both sleep quality and anxiety, mostly subjective questionnaires. Result: this meta-analysis found valerian improved subjective sleep quality across 10 studies with 1,065 participants, and reduced anxiety across 8 studies with 535 participants. Quality note: effects varied with the type of valerian extract used, with whole root or rhizome extracts performing more reliably than other preparations.
- Older multi-study systematic review of valerian for sleep: an earlier, smaller pooling of sleep trials, referenced within the umbrella review’s own assessment of the field. Outcome type: subjective sleep measures. Result: modest, inconsistent benefit. Quality note: the umbrella review flags these earlier reviews as suffering from the same small-sample, short-duration limitations that persist across the field.
- Cochrane review of valerian for anxiety: a formal review of anxiety-specific trials, cited within the broader evidence base as showing thin, inconclusive support. No objective biomarker confirmed a calming effect at a scale separate from self-report.
Where the reviews agree
Across every review, valerian shows a good safety profile and rarely produces serious adverse effects. The reviews also agree that people taking valerian often report feeling like they slept better or felt calmer. Where the sample size is largest, that self-reported benefit shows up most clearly: the 2020 meta-analysis, pooling nearly 7,000 participants, found measurable improvement on subjective sleep quality and anxiety scores. The umbrella review reaches a similar conclusion from the opposite direction: it finds no proof of efficacy on objective outcomes, but does not dispute that subjective ratings tend to improve.
Where the reviews disagree and why
The disagreement is not really about whether valerian works, it is about what counts as working. Reviews that lean on subjective outcomes, like sleep questionnaires, tend to report benefit tied to conditions covered under sleep disorders. Reviews that weight objective measurement more heavily, or that grade methodological quality strictly, come back with a flat or absent effect. The single most repeated criticism across all of them is heterogeneity: valerian sold as a supplement is not one standardized product, and studies test different extracts, different plant parts, and different concentrations under the same name. That matters because more studies does not mean stronger evidence when those studies are not testing the same thing. Sixty studies of sixty different preparations answer sixty smaller questions, not one big one, and the 2020 meta-analysis itself points to extract type as the reason its own pooled results vary as much as they do.
What the research says about valerian and sleep
Most of the clinical trials testing valerian tablets for sleep did not recruit people with a diagnosed sleep disorder. Instead, they enrolled adults who described themselves as poor sleepers or as having insomnia symptoms, based on self-report rather than a clinical evaluation. That distinction matters because it shapes what the studies could actually measure. The outcomes tracked across these trials tend to be perceived sleep quality, how long it took participants to fall asleep, and how often they woke during the night.
A systematic review of nine randomized, placebo-controlled trials found the results contradicted each other, with wide differences in who was studied, how the trials were designed, and how rigorously they were run. Some trials reported that people slept better on valerian than on placebo. Others found no meaningful difference at all. The review concluded that the evidence for valerian as an insomnia treatment is inconclusive.
One trial that did report benefit followed 128 people given an aqueous valerian extract and found a significant drop in how long participants felt it took them to fall asleep, along with improved sleep quality. That improvement was strongest in people who already described themselves as poor or irregular sleepers, in smokers, and in those with long sleep onset times. Night waking, dream recall, and next-day sleepiness barely moved in that same trial. Where effects appear, they tend to be modest rather than dramatic, and several reports describe benefit building over repeated nightly use rather than showing up the first night, though this pattern has not been consistently demonstrated.
Trials in postmenopausal women, people on hemodialysis, and older adults have also produced mixed results, without a consistent signal across those groups. Direct comparisons of valerian root versus melatonin for sleep are limited, largely because the two are studied for different problems. Melatonin research focuses on circadian timing, the body’s internal clock, while valerian research focuses on perceived sleep quality. That difference in what each is designed to affect makes a head-to-head comparison difficult to draw from the existing evidence.
Why a sleep questionnaire improves when the sleep recording does not
Sleep research uses two different kinds of measurement, and they do not always agree. Subjective measures ask a person to report on their own sleep: a diary filled out each morning, a validated questionnaire, or a rating of how rested someone feels on waking. Objective measures record what the body actually does during the night. Actigraphy uses a wrist-worn sensor to track movement as a proxy for sleep and wake, while polysomnography records brain waves, eye movement, and muscle activity in a sleep lab to map the stages of sleep directly.
A controlled trial on valerian illustrates how these two kinds of data can pull apart. Donath and colleagues’ evaluation of valerian extract found that participants rated their sleep quality as improved, while polysomnography showed no meaningful change in sleep structure or in how long it took them to fall asleep compared to placebo. The people taking valerian felt they had slept better. The recording equipment did not see a difference.
That gap is not automatically a measurement error. Feeling more rested is a real outcome, even when it does not show up as a change in brain wave patterns. A self-report score can move because a person expects the supplement to help, because they worry less about sleep once they believe they are doing something about it, or because morning recall of a night’s sleep is shaped by mood and expectation rather than a precise readout of what happened. None of that makes the improvement fake. It means the improvement is happening somewhere questionnaires can detect and machines are not built to measure the same way.
When someone asks whether valerian works, they are usually asking about this subjective experience, since it is the outcome most likely to shift. This same split between what people report and what a lab records shows up across many sleep aids, not just valerian, so it does not by itself say much about the supplement’s biology.
What the research says about valerian and anxiety
Does valerian root actually work for anxiety?
The honest answer is that no one has run enough good trials to say. A Cochrane systematic review of valerian for anxiety disorders found only one small randomized trial that met its inclusion criteria, a study of 36 patients comparing valerian against placebo and diazepam over four weeks. That trial found no significant difference between valerian and placebo on anxiety scores, and diazepam produced greater improvement than valerian on one of the two measures used. One small trial cannot settle a question this size, and the review’s conclusion was that there is not enough evidence to draw a conclusion either way, not that valerian was proven ineffective.
What anxiety outcomes have been measured
The same Cochrane review relied on standard anxiety rating scales, including the Hamilton Anxiety Rating Scale and the State-Trait Anxiety Inventory, to compare valerian against placebo and diazepam. Beyond that trial, the small pool of anxiety research on valerian root tends to look at situational anxiety, moments like dental procedures or exam-taking, rather than a diagnosed anxiety disorder. That distinction matters. Generalized anxiety, the kind that meets diagnostic criteria and persists across contexts, is a different subject than the anticipatory anxiety someone feels in a dentist’s chair, and most of what exists on valerian speaks to the latter. Sample sizes across this body of work stay small and the trial periods stay short, which limits how much weight any single result can carry.
Daytime use versus night-time use
Valerian root for anxiety during the day creates a practical tension that valerian for sleep does not. The same sedating quality that makes valerian appealing at bedtime is the quality you would want to avoid while driving, working, or making decisions. Anyone weighing valerian root dosage for anxiety during waking hours is really weighing whether some drowsiness is an acceptable tradeoff for a possible calming effect, and the available trial does not answer whether that tradeoff pays off. For anxiety that shows up regularly rather than around a single event, cognitive behavioral therapy has a research base that valerian does not.
How valerian is thought to work in the body
The most discussed proposal centers on GABA, the main inhibitory signaling chemical in the nervous system, which calms nerve activity when it binds to its receptors. A laboratory study on Valeriana officinalis extracts and rat brain tissue examined how valerenic acid and related compounds interact with the GABA-A receptor, one of the main docking sites for this calming signal. That work was done on rat brain tissue in a dish, not in a person taking a capsule, so it shows a plausible interaction rather than a confirmed effect in humans.
A separate line of work looked at valerenic acid’s sedative activity directly. A study on valerenic acid’s central nervous system effects in mice found measurable sedative activity in the animals tested. This adds to the case that valerenic acid does something to the nervous system, but a mouse’s response to a compound does not automatically predict what happens after a person swallows a standardized extract with a different mix of constituents.
